ResearcherCharles UniversityNo recent work listed

Michal Anděl

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110361143. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper

Papers 2

Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus. Last author DOI 10.1016/j.pan.2016.05.005 ↗
[miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?]. Co-author PMID 25894267 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pavel Škrha · 2 shared papers, 2015–2016 · strength 0.14
- Paper [miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?]. PMID 25894267 ↗
- Paper Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus. DOI 10.1016/j.pan.2016.05.005 ↗
Jan Škrha · 2 shared papers, 2015–2016 · strength 0.14
- Paper [miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?]. PMID 25894267 ↗
- Paper Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus. DOI 10.1016/j.pan.2016.05.005 ↗
Premysl Fric · 1 shared paper, 2016 · strength 0.07
- Paper Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus. DOI 10.1016/j.pan.2016.05.005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.